Ensnaring membrane type 1-matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase (TIMP)-2 using the haemopexin domain of the protease as a carrier: a targeted approach in cancer inhibition
Authors:
Open Access
- 7 February 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (14) , 22685-22699
Abstract
Oncotarget | https://doi.org/10.18632/oncotarget.15165 Bingjie Jiang, Yan Zhang, Jian Liu, Anastasia Tsigkou, Magdalini Rapti, Meng Huee Lee Ensnaring membrane type 1-matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase (TIMP)-2 using the haemopexin domain of the protease as a carrier: a targeted approach in cancer inhibitionKeywords
This publication has 44 references indexed in Scilit:
- TIMPs: versatile extracellular regulators in cancerNature Reviews Cancer, 2016
- The membrane tethered matrix metalloproteinase MT1-MMP at the forefront of melanoma cell invasion and metastasisPharmacological Research, 2016
- Novel MT1-MMP Small-Molecule Inhibitors Based on Insights into Hemopexin Domain Function in Tumor GrowthCancer Research, 2012
- Matrix metalloproteinases (MMPs) in health and disease: an overviewFrontiers in Bioscience-Landmark, 2006
- Gelatinase-mediated migration and invasion of cancer cellsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2005
- A Theoretical Model of Type I Collagen Proteolysis by Matrix Metalloproteinase (MMP) 2 and Membrane Type 1 MMP in the Presence of Tissue Inhibitor of Metalloproteinase 2Journal of Biological Chemistry, 2004
- Characterization of the Role of the “MT-loop”Journal of Biological Chemistry, 2001
- Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: Correlations with tumor invasion and metastasisHead & Neck, 1999
- Preclinical and Clinical Studies of MMP Inhibitors in CancerAnnals of the New York Academy of Sciences, 1999
- Crystal structure of the complex formed by the membrane type 1‐matrix metalloproteinase with the tissue inhibitor of metalloproteinases‐2, the soluble progelatinase A receptorThe EMBO Journal, 1998